Spatial Distribution of Plasmodium falciparum and Plasmodium vivax in Northern Ethiopia by Microscopic, Rapid Diagnostic Test, Laboratory Antibody, and Antigen Data

J Infect Dis. 2022 Mar 2;225(5):881-890. doi: 10.1093/infdis/jiab489.

Abstract

Background: Determining malaria transmission within regions of low, heterogenous prevalence is difficult. A variety of malaria tests exist and range from identification of diagnostic infection to testing for prior exposure. This study describes the concordance of multiple malaria tests using data from a 2015 household survey conducted in Ethiopia.

Methods: Blood samples (n=2279) from 3 regions in northern Ethiopia were assessed for Plasmodium falciparum and Plasmodium vivax by means of microscopy, rapid diagnostic test, multiplex antigen assay, and multiplex assay for immunoglobulin G (IgG) antibodies. Geospatial analysis was conducted with spatial scan statistics and kernel density estimation to identify malaria hot spots by different test results.

Results: The prevalence of malaria infection was low (1.4% by rapid diagnostic test, 1.0% by microscopy, and 1.8% by laboratory antigen assay). For P. falciparum, overlapping spatial clusters for all tests and an additional 5 unique IgG clusters were identified. For P. vivax, clusters identified with bead antigen assay, microscopy, and IgG partially overlapped.

Conclusions: Assessing the spatial distribution of malaria exposure using multiple metrics can improve the understanding of malaria transmission dynamics in a region. The relative abundance of antibody clusters indicates that in areas of low transmission, IgG antibodies are a more useful marker to assess malaria exposure.

Keywords: Plasmodium falciparum; Plasmodium vivax; Ethiopia; GIS; antibodies; geospatial analysis; infection test.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Diagnostic Tests, Routine
  • Ethiopia / epidemiology
  • Humans
  • Immunoglobulin G
  • Malaria* / epidemiology
  • Malaria, Falciparum* / diagnosis
  • Malaria, Falciparum* / epidemiology
  • Malaria, Vivax* / diagnosis
  • Malaria, Vivax* / epidemiology
  • Plasmodium falciparum
  • Plasmodium vivax
  • Prevalence

Substances

  • Immunoglobulin G